SRx Health Solutions, Inc. announced on March 16, 2026, it entered a Securities Purchase Agreement to sell up to 10,000 shares of Series B convertible preferred stock and warrants for up to $8 million, with an initial closing generating approximately $4.528 million from the sale of 5,660 preferred shares and over 22 million warrants.